Sneddon's Syndrome

1999 ◽  
Vol 11 (1) ◽  
pp. 62
Author(s):  
Kyoung-Ae Jang ◽  
Man-Heui Han ◽  
Jee-Ho Choi ◽  
Kyung-Jeh Sung ◽  
Kee-Chan Moon ◽  
...  
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome

scholarly journals 36. Recurrent strokes in younger patient with rash: a case of Sneddon’s syndrome

2018 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
Himashi Anver ◽  
Shirish Dubey ◽  
Siwalik Banerjee ◽  
Tanya Potter ◽  
Andrew Short ◽  
...  
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome ◽  
Younger Patient ◽  
Recurrent Strokes

Neuropathological findings in Sneddon's syndrome

Neurology ◽  
2003 ◽  
Vol 60 (7) ◽  
pp. 1181-1182 ◽  
Author(s):  
D. A. Hilton ◽  
D. Footitt
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome

Sneddon's syndrome

2009 ◽  
Vol 283 (1-2) ◽  
pp. 252
Author(s):  
J.L. De Reuck
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome

A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: Kidney involvement in sneddon's syndrome

1995 ◽  
Vol 26 (3) ◽  
pp. 511-515 ◽  
Author(s):  
Hiroshi Ohtani ◽  
Hirokazu Imai ◽  
Tadashi Yasuda ◽  
Hideki Wakui ◽  
Atsushi Komatsuda ◽  
...  
Keyword(s):  
Blood Vessels ◽  
Cerebral Blood Vessels ◽  
Livedo Racemosa ◽  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome ◽  
Kidney Involvement

scholarly journals Therapeutic Perspectives in Sneddon’s Syndrome

2021 ◽  
Vol 18 (5) ◽  
pp. 73-80
Author(s):  
Oana-Petronela Oancea ◽  
Alexandru-Dan Costache ◽  
Daniela Olaru ◽  
Răzvan Platon ◽  
Florin Mitu
Keyword(s):  
Chronic Disease ◽  
Disease Progression ◽  
Oral Anticoagulant ◽  
Oral Anticoagulant Therapy ◽  
Protein Z ◽  
Livedo Racemosa ◽  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome ◽  
Cerebrovascular Events ◽  
Therapeutic Perspective

Abstract Sneddon’s syndrome is a rare but severe progressive chronic disease, characterized by multiple discoloration skin patches called Livedo racemosa and recurrent cerebrovascular events. It mainly affects women aged around 40. Considering the two main forms, antiphospholipid (APS) positive and negative, the available treatments are directed at either one of them. The idiopathic form (APS negative) is associated with a more severe prognosis as chronic oral anticoagulant therapy (COA) is more difficult to manage. One therapeutic perspective in controlling disease progression in these patients is by understanding the protein Z deficiency in these patients as a deciding factor in the success of the COA therapy.

Sneddon's syndrome

2010 ◽  
pp. 405-412
Author(s):  
Jacques L. De Reuck ◽  
Jan L. De Bleecker
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome

Sneddon's syndrome: A systemic arterio-occlusive disorder

1995 ◽  
Vol 26 (2) ◽  
pp. 368-372
Author(s):  
Khalid Al Meshari ◽  
Abdullah Al Eisa ◽  
Mohammed Akhtar
Keyword(s):  
Sneddon's Syndrome ◽  
Sneddon’S Syndrome
Sign in / Sign up

Export Citation Format

Share Document